SCHEMBL29337991

SCHEMBL29337991

N#Cc1cccc(Oc2cc(F)c3[nH]ccc3c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 1/20 0.44
▸ CHUK O15111 1/20 0.44
▸ EGFR P00533 1/20 0.40
▸ ERBB2 P04626 1/20 0.40
▸ ERBB3 P21860 1/20 0.40
▸ ERBB4 Q15303 1/20 0.40
▸ FFAR1 O14842 1/20 0.39
▸ FFAR4 Q5NUL3 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ BRD4 O60885 1/20 0.38
▸ IMPDH2 P12268 1/20 0.38
▸ IMPDH1 P20839 1/20 0.38
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ PDE4C Q08493 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ HAO1 Q9UJM8 3/20 0.37
▸ JAK2 O60674 1/20 0.36
▸ JAK1 P23458 1/20 0.36
▸ JAK3 P52333 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31176754 0.78 IMPDH2 (0.61) IKBKBCHUKEGFRERBB2ERBB3
SCHEMBL29336705 0.77 F10 (0.55) —
SCHEMBL8530077 0.75 IMPDH2 (0.50) IKBKBCHUKIMPDH2IMPDH1SLC6A2
SCHEMBL8379001 0.74 PDE4A (0.54) FFAR1FFAR4MAP4K4PDE4APDE4B
SCHEMBL7072557 0.73 PDE4A (0.50) FFAR1FFAR4MAP4K4PDE4APDE4B
SCHEMBL7069974 0.73 PDE4A (0.50) FFAR1FFAR4MAP4K4PDE4APDE4B
SCHEMBL27839327 0.73 PDE4A (0.53) FFAR1FFAR4MAP4K4PDE4APDE4B
SCHEMBL921798 0.72 FFAR1 (0.50) FFAR1FFAR4MAP4K4PDE4APDE4B
SCHEMBL10923033 0.71 PDE4A (0.55) MAP4K4PDE4APDE4BPDE4CPDE4D
SCHEMBL923535 0.70 ALOX5 (0.50) FFAR1FFAR4PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239784-A1 INDOLE COMPOUNDS AND METHODS OF USE GENZYME CORPORATION 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239784-A1 INDOLE COMPOUNDS AND METHODS OF USE CFTR, INMT, IDO1 IKBKB 802/4885CHUK 849/4885EGFR 2837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback